MedWatch

Medtech company raises millions and replaces majority of board members

Medtech company RSP Systems completed its third series B financing round, ensuring the firm a total amount of EUR 13.1 million (USD 14.96 million). The funding is to facilitate European launch of a non-invasive glucose monitoring device. At the same time, the company says goodbye to five in eight board members.

Foto: RSP Systems/PR

For the third time in eight months, Danish medtech company RSP Systems has closed a series B financing round that, this time, brought in EUR 2.75 million (USD 3.14 million) to the company.

The total amount of the series B funding thus increases to EUR 13.1 million (USD 14.96 million), which, according to CSO Anders Weber, brought the financing round to a final end.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier